全文获取类型
收费全文 | 3040篇 |
免费 | 210篇 |
国内免费 | 16篇 |
专业分类
耳鼻咽喉 | 59篇 |
儿科学 | 75篇 |
妇产科学 | 66篇 |
基础医学 | 285篇 |
口腔科学 | 41篇 |
临床医学 | 364篇 |
内科学 | 650篇 |
皮肤病学 | 43篇 |
神经病学 | 257篇 |
特种医学 | 95篇 |
外科学 | 711篇 |
综合类 | 73篇 |
一般理论 | 1篇 |
预防医学 | 157篇 |
眼科学 | 44篇 |
药学 | 120篇 |
中国医学 | 5篇 |
肿瘤学 | 220篇 |
出版年
2023年 | 24篇 |
2022年 | 51篇 |
2021年 | 115篇 |
2020年 | 75篇 |
2019年 | 93篇 |
2018年 | 126篇 |
2017年 | 73篇 |
2016年 | 92篇 |
2015年 | 86篇 |
2014年 | 124篇 |
2013年 | 134篇 |
2012年 | 228篇 |
2011年 | 250篇 |
2010年 | 124篇 |
2009年 | 115篇 |
2008年 | 173篇 |
2007年 | 200篇 |
2006年 | 154篇 |
2005年 | 134篇 |
2004年 | 132篇 |
2003年 | 125篇 |
2002年 | 121篇 |
2001年 | 41篇 |
2000年 | 30篇 |
1999年 | 40篇 |
1998年 | 28篇 |
1997年 | 19篇 |
1996年 | 16篇 |
1995年 | 13篇 |
1994年 | 15篇 |
1993年 | 15篇 |
1992年 | 20篇 |
1991年 | 17篇 |
1990年 | 18篇 |
1989年 | 26篇 |
1988年 | 14篇 |
1987年 | 15篇 |
1986年 | 23篇 |
1985年 | 18篇 |
1984年 | 13篇 |
1983年 | 11篇 |
1979年 | 15篇 |
1978年 | 7篇 |
1977年 | 10篇 |
1976年 | 6篇 |
1975年 | 7篇 |
1974年 | 15篇 |
1973年 | 13篇 |
1972年 | 6篇 |
1971年 | 9篇 |
排序方式: 共有3266条查询结果,搜索用时 15 毫秒
141.
142.
Splenomegaly, pancytopenia and pregnancy: a case report and review of the literature 总被引:1,自引:0,他引:1
We present a 35-year-old previously healthy primigravida who presented at 264/7 weeks of gestation with pancytopenia and hepatosplenomegaly. She received 10 transfusions and delivered at 344/7 weeks of gestation by cesarean section. Two months later following splenectomy, she was diagnosed with malaria. Physicians should have a high index of suspicion for malaria in the context of splenomegaly and pancytopenia in pregnancy even in the absence of fever. 相似文献
143.
C L Astry S Nelson G H Karam W R Summer 《The American review of respiratory disease》1987,135(5):1015-1019
Clindamycin is speculated to have select advantages in the treatment of certain infections because biologically active antibiotic is internalized by macrophages and PMNs in vitro. By challenging pulmonary host defenses with various bacterial species as probes, we were able to evaluate clindamycin-phagocyte interaction in vivo. A murine model was developed using an implanted mini-osmotic pump to maintain constant clindamycin blood levels at 1/4 MIC (1 microgram/ml). Mice pretreated for 24 h with clindamycin killed a significantly greater percentage of intratracheally inoculated Bacteroides thetaiotaomicron in 4 h than did control animals (37 +/- 2% versus 7 +/- 5%). The enhancing effects of clindamycin on pulmonary defenses could not be duplicated by a 1-h preincubation of B. theta in 1/4 MIC of clindamycin before inoculation into untreated mice. Clindamycin blood levels of 1 microgram/ml did not alter the rate at which Pseudomonas aeruginosa (clindamycin-resistant) was killed by pulmonary defenses, suggesting that clindamycin did not cause nonspecific activation of phagocytic defenses. Both PMNs and alveolar macrophages lavaged from the lungs of clindamycin-treated mice contained bioassayable concentrated intracellular antibiotic. The presence of intracellular antibiotic was further supported by experiments in which the intrapulmonary killing of large numbers of Staphylococcus aureus (sensitive, but not resistant organisms) was significantly enhanced (89 +/- 5 versus 70 +/- 5%) by clindamycin pretreatment. In contrast, phagocytes lavaged from mice with constant 1/4 MIC (4 micrograms/ml) blood levels of penicillin G had no detectable intracellular antibiotic activity and did not augment the intrapulmonary killing of B. theta.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
144.
Reem A. Mustafa Fadi Bdair Elie A. Akl Amit X. Garg Heather Thiessen-Philbrook Hassan Salameh Sood Kisra Gihad Nesrallah Ahmad Al-Jaishi Parth Patel Payal Patel Ahmad A. Mustafa Holger J. Schünemann 《Clinical journal of the American Society of Nephrology》2016,11(3):442-457
Background and objectives
Lowering the dialysate temperature may improve outcomes for patients undergoing chronic hemodialysis. We reviewed the reported benefits and harms of lower temperature dialysis.Design, setting, participants, & measurements
We searched the Cochrane Central Register, OVID MEDLINE, EMBASE, and Pubmed until April 15, 2015. We reviewed the reference lists of relevant reviews, registered trials, and relevant conference proceedings. We included all randomized, controlled trials that evaluated the effect of reduced temperature dialysis versus standard temperature dialysis in adult patients receiving chronic hemodialysis. We followed the Grading of Recommendations Assessment, Development and Evaluation approach to assess confidence in the estimates of effect (i.e., the quality of evidence). We conducted meta-analyses using random effects models.Results
Twenty-six trials were included, consisting of a total of 484 patients. Compared with standard temperature dialysis, reduced temperature dialysis significantly reduced the rate of intradialytic hypotension by 70% (95% confidence interval, 49% to 89%) and significantly increased intradialytic mean arterial pressure by 12 mmHg (95% confidence interval, 8 to 16 mmHg). Symptoms of discomfort occurred 2.95 (95% confidence interval, 0.88 to 9.82) times more often with reduced temperature compared with standard temperature dialysis. The effect on dialysis adequacy was not significantly different, with a Kt/V mean difference of −0.05 (95% confidence interval, −0.09 to 0.01). Small sample sizes, loss to follow-up, and a lack of appropriate blinding in some trials reduced confidence in the estimates of effect. None of the trials reported long-term outcomes.Conclusions
In patients receiving chronic hemodialysis, reduced temperature dialysis may reduce the rate of intradialytic hypotension and increase intradialytic mean arterial pressure. High–quality, large, multicenter, randomized trials are needed to determine whether reduced temperature dialysis affects patient mortality and major adverse cardiovascular events. 相似文献145.
146.
AIM: To investigate and compare the effects of spinal D-(-)-2-amino-7-phosphonoheptanoic acid (AP-7) and 6-cyano-7-nitroquinoxaline-2,3-dione disodium (CNQX), two glutamate receptor antagonists, on the responses of dorsal horn neurons to colorectal distension (CRD) in adult rats exposed to neonatal colon irritation (CI). METHODS: Hypersensitive SD rats were generated by CI during postnatal days 8, 10 and 12. Experiments on adult rats were performed using extracellular single-unit recording. The effects of spinal application of AP-7 (0.001, 0.01, 0.1, 1 mmoL) were tested on the CRD-evoked neuronal responses in 16 controls and 17 CI rats. The effects of CNQX (0.2, 2, 5, 10 μmoL) were also tested on the CRD-evoked responses of 17 controls and 18 CI neurons. RESULTS: (1) The average responses of lumbosacral neurons to all intensities of CRD in CI rats were significantly higher than those in control rats; (2) In control rats, AP-7 (0.01 mmoL) had no significant effect on the neuronal response to all intensities of CRD (20, 40, 60, 80 mmHg); while AP-7 (0.1 mmoL) inhibited the neuronal response to 80-mmHg CRD. By contrast, in CI rats, AP-7 (0.01-1 mmoL) attenuated the CRD-evoked neuronal responses to all distention pressures in a dose-dependent manner; (3) In control rats, CNQX (2 μmoL) had no significantly effect on the neuronal response to all intensities of CRD; however, CNQX (5 μmoL) significantly attenuated the responses to CRD in the 40-80 mmHg range. By contrast, CNQX (2-10 μmoL) significantly decreased the neuronal responses in CI rats to non-noxious and noxious CRD in a dose-dependent manner. CONCLUSION: Our results suggest that spinal N-methyl-D-aspartate (NMDA) and non-NMDA receptors may contribute to the processing of central sensitivity in a neonatal CI rat model, but they may play different roles in it. 相似文献
147.
Robert?SlingerEmail author Marc?Desjardins Anne?E?McCarthy Karam?Ramotar Peter?Jessamine Christiane?Guibord Baldwin?Toye 《BMC infectious diseases》2004,4(1):36
Background
Salmonella spp. with reduced susceptibility to fluoroquinolones have higher than usual MICs to these agents but are still considered "susceptible" by NCCLS criteria. Delayed treatment response to fluoroquinolones has been noted, especially in cases of enteric fever due to such strains. We reviewed the ciprofloxacin susceptibility and clinical outcome of our recent enteric fever cases.Methods
Salmonella enterica Serotype Typhi (S. Typhi) and Serotype Paratyphi (S. Paratyphi) blood culture isolates (1998–2002) were tested against nalidixic acid by disk diffusion (DD) and agar dilution (AD) and to ciprofloxacin by AD using NCCLS methods and interpretive criteria. Reduced fluoroquinolone susceptibility was defined as a ciprofloxacin MIC of 0.125–1.0 mg/L. The clinical records of patients treated with ciprofloxacin for isolates with reduced fluoroquinolone susceptibility were reviewed.Results
Seven of 21 (33%) S. Typhi and S. Paratyphi isolates had reduced susceptibility to fluoroquinolones (MIC range 0.125–0.5 mg/L). All 7 were nalidixic acid resistant by DD (no zone) and by AD (MIC 128- >512 mg/L). The other 14 isolates were nalidixic acid susceptible and fully susceptible to ciprofloxacin (MIC range 0.015–0.03 mg/L).Five of the 7 cases were treated initially with oral ciprofloxacin. One patient remained febrile on IV ciprofloxacin until cefotaxime was added, with fever recurrence when cefotaxime was discontinued. Two continued on oral or IV ciprofloxacin alone but had prolonged fevers of 9–10 days duration, one was switched to IV beta-lactam therapy after remaining febrile for 3 days on oral/IV ciprofloxacin and one was treated successfully with oral ciprofloxacin. Four of the 5 required hospitalization.Conclusions
Our cases provide further evidence that reduced fluoroquinolone susceptibility of S. Typhi and S. Paratyphi is clinically significant. Laboratories should test extra-intestinal Salmonella spp. for reduced fluoroquinolone susceptibility.148.
149.